the joints, either due to playing sports or through work are more likely to develop OA.
There have been incidences of OA in people who have been born with some kind of genetic condition that affects the joints in some way. OA is most commonly found in the hands.
Treatment Options
Exercises to keep joints flexible and improve muscle strength
Many different medications are used to control pain, including corticosteroids and NSAIDs. Glucocorticoids injected into joints that are inflamed and not responsive to NSAIDS. For mild pain without inflammation, acetaminophen may be used.
Heat/cold therapy for temporary pain relief
Joint protection to prevent strain or stress on painful joints
Surgery (sometimes) to relieve chronic pain in damaged joints
About the author:
James Hunt has spent 15 years as a professional writer and researcher covering stories that cover a whole spectrum of interest. Read more at www.osteoarthritis- central.info
Written By: James Hunt

People's Pharmacy: Supplement for arthritis raised cholesterol - Tuscaloosa News
studies do not demonstrate any benefits for mild to moderate ... My 15-year-old son had low HDL and a poor cholesterol profile at his checkup. (Total cholesterol was 146, HDL 29 and LDL 96). So for 10 months,
Rheumatoid Arthritis Signaling Protein GM-CSF Reverses Alzheimer's Disease In Mouse ... - Medical News Today
A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease ...
Disease Activity Is Main Factor in Disability from Rheumatoid Arthritis - Newswise
Source: Wolters Kluwer Health: Lippincott Williams & Wilkins Newswise — For people living with rheumatoid arthritis (RA), the level of disease activity—measured using the standard DAS 28 score—is the factor most ...
Chelsea Therapeutics' experimental rheumatoid arthritis drug trial gets FDA nod - Small Cap Network
As we told our readers last Friday, Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) was set to run higher in anticipation of FDA news. This morning, the company has announced that the U.S. Food and ...
Chelsea Therapeutics gets FDA OK to start study - Forbes
CHARLOTTE, N.C. -- Chelsea Therapeutics International Ltd. said Thursday it received Food and Drug Administration clearance to start a midstage study on a potential rheumatoid arthritis drug. The company said ...
Arthritis: The Secret to Treating Alzheimer's? - Redorbit.com
(Ivanhoe Newswire) -- Researchers know that people with rheumatoid arthritis are less likely to develop Alzheimer's disease. Now, they may have an explanation why. A new study shows a protein released in ...
Celebrex Appears Easier on Stomach for Arthritis Patients - MedicineNet.com
THURSDAY, June 17 (HealthDay News) -- Patients who take the painkiller celecoxib for arthritis pain and inflammation are less likely to suffer gastrointestinal damage than those who take diclofenac plus omeprazole , a ...